autologous


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

au·tol·o·gous

 (ô-tŏl′ə-gəs)
adj.
Derived or transferred from the same individual's body: autologous blood donation; an autologous bone marrow transplant.
[auto- + -logous (as in homologous).]
au·tol′o·gous·ly adv.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

autologous

(ɔːˈtɒləɡəs)
adj
(Medicine) (of a tissue graft, blood transfusion, etc) originating from the recipient rather than from a donor
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

au•tol•o•gous

(ɔˈtɒl ə gəs)

adj.
from the same organism: an autologous graft.
[1920–25]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.autologous - derived from organisms of the selfsame individualautologous - derived from organisms of the selfsame individual; "autologous blood donation"
heterologous - derived from organisms of a different but related species; "a heterologous graft"
homologous - corresponding or similar in position or structure or function or characteristics; especially derived from an organism of the same species; "a homologous tissue graft"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

au·tol·o·gous

a. autólogo-a, que indica algo que proviene del propio individuo.
English-Spanish Medical Dictionary © Farlex 2012

autologous

adj autólogo
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
North America is anticipated to remain the leading market for autologous fat grafting during the forecast period 2019-2029.
Demand for Autologous Fat Grafting Positively Endorsed by Rising Breast Augmentation Procedures, rep
Summary: North America is anticipated to remain the leading market for autologous fat grafting during the forecast period 2019-2029.
Demand for Autologous Fat Grafting Positively Endorsed by Rising Breast Augmentation Procedures, rep
(NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today, that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2019, and provide a corporate update, at 8:00 a.m, Eastern Daylight Time, on Tuesday, August 13, 2019.
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update
The Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF (NurOwn) cells will be directed at USC by neurologist Daniel Pelletier.
Third Clinical Site for Phase 2 Progressive MS Trial
Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumours, has collaborated with United States-based Merck (known as MSD outside the US and Canada), through a subsidiary.
Tessa Therapeutics collaborates with Merck
(NASDAQ: BCLI) announced that the first patient has been enrolled in its Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF cells in participants with progressive multiple sclerosis (MS).
First Patient Enrolled In Phase 2 Trial Of Progressive MS Therapy
The company said the ovarian Phase 2 double-blind study is active and enrolling approximately 99 patients who are being randomized in a 2:1 ratio to receive either the autologous cancer stem cell-targeting immunotherapy or autologous monocytes as a comparator.
AIVITA announces completion of treatment of its first ovarian cancer patient
The session will also provide a comparative review of HYALOFAST in comparison to ACI, or Autologous Chondrocyte Implantation, and MACI, or Matrix Autologous Chondrocyte Implantation, two-step surgeries requiring cell cultivation.
Anika Therapeutics to showcase Hyalofast at ICRS
Timothy Smith, co-founder of Octane Biotech with Ian Grant, said, "As continuing shareholders and directors of Octane Biotech, we welcome the expanded engagement of Lonza to significantly accelerate and reinforce the role of the Cocoon system as a game changer in the autologous cell therapy manufacturing space.
Lonza Acquires Octane Biotech
The authority will introduce guidelines through a new Stem Cell Scientific Board for those seeking to offer Autologous Stem Cell therapy (cells derived from one's own fat and blood).
Stem cell therapy for aesthetic needs to attract health tourists
THURSDAY, June 21, 2018 (HealthDay News) -- Patients undergoing autologous post-mastectomy breast reconstruction have greater satisfaction than those undergoing implant reconstruction, and the odds of developing complications are significantly higher for autologous reconstruction types versus expander-implant techniques, according to two studies published online June 20 in JAMA Surgery.
Greater Satisfaction With Autologous Breast Reconstruction; And, likelihood of complications up for autologous reconstruction versus expander-implant technique

Dictionary browser ?
Full browser ?